From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 3,685.00
+355.00 (10.66%)
At close: Aug 11, 2026
From Bio Co.,Ltd Revenue
From Bio Co.,Ltd had revenue of 19.17B KRW in the quarter ending March 31, 2026, with 3.62% growth. This brings the company's revenue in the last twelve months to 72.83B, up 9.92% year-over-year. In the year 2025, From Bio Co.,Ltd had annual revenue of 72.16B with 7.41% growth.
Revenue (ttm)
72.83B
Revenue Growth
+9.92%
P/S Ratio
0.29
Revenue / Employee
520.23M
Employees
140
Market Cap
20.86B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.16B | 4.98B | 7.41% |
| Dec 31, 2024 | 67.18B | 457.90M | 0.69% |
| Dec 31, 2023 | 66.72B | -32.61B | -32.83% |
| Dec 31, 2022 | 99.33B | -35.77B | -26.48% |
| Dec 31, 2021 | 135.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daedong Metals | 101.06B |
| NPK Co.,Ltd | 86.11B |
| Softcen | 56.79B |
| PAKERS.Co.,Ltd. | 51.74B |
| S&W Corporation | 47.76B |
| TOEBOX KOREA.Ltd. | 40.49B |
| DMOA Co., Ltd | 27.53B |
| Dongil Steelux | 23.10B |